Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
-
Page/Page column 64; 70
(2010/11/25)
More Articles about upstream products of 925450-45-9